作者:
Simon A,Broadley [1]
;
Michael H,Barnett [2]
;
Mike,Boggild [3]
;
Bruce J,Brew [4]
;
Helmut,Butzkueven [5]
;
Robert,Heard [6]
;
Suzanne,Hodgkinson [7]
;
Allan G,Kermode [8]
;
Jeannette,Lechner-Scott [9]
;
Richard A L,Macdonell [10]
;
Mark,Marriott [11]
;
Deborah F,Mason [12]
;
John,Parratt [13]
;
Stephen W,Reddel [2]
;
Cameron P,Shaw [14]
;
Mark,Slee [15]
;
Judith,Spies [2]
;
Bruce V,Taylor [16]
;
William M,Carroll [17]
;
Trevor J,Kilpatrick [16]
;
John,King [18]
;
Pamela A,McCombe [19]
;
John D,Pollard [2]
;
Ernest,Willoughby [20]
;
MS Neurology Group of the Australian and New Zealand Association of Neurologists
作者单位:
School of Medicine, Griffith University, Gold Coast Campus, QLD 4222, Australia; Department of Neurology, Gold Coast University Hospital, Southport, QLD, Australia. Electronic address: simon.broadley@griffith.edu.au.
[1]
Brain and Mind Research Institute, University of Sydney, Camperdown, NSW, Australia.
[2]
Department of Neurology, The Townsville Hospital, Douglas, QLD, Australia.
[3]
Department of Neurology and St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, University of New South Wales, Darlinghurst, NSW, Australia.
[4]
Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia; Department of Neurology, Eastern Health and Monash University, 2/5 Arnold Street, Box Hill VIC 3128, Australia.
[5]
Westmead Clinical School, University of Sydney, NSW, Australia.
[6]
South Western Sydney Clinical School, University of New South Wales, NSW, Australia.
[7]
Centre for Neuromuscular and Neurological Disorders, University of Western Australia, WA, Australia; Institute of Immunology and Infectious Diseases, Murdoch University, WA, Australia.
[8]
Hunter Medical Research Institute, The University of Newcastle, New Lambton, NSW, Australia.
[9]
Department of Neurology, Austin Health, Heidelberg, VIC, Australia.
[10]
Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
[11]
Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.
[12]
Central Clinical School, University of Sydney, NSW, Australia.
[13]
School of Medicine, Deakin University, VIC, Australia.
[14]
Flinders Medical Centre, Flinders University, SA, Australia.
[15]
Menzies Research Institute, University of Tasmania, TAS, Australia.
[16]
Centre for Neuromuscular and Neurological Disorders, University of Western Australia, WA, Australia.
[17]
Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.
[18]
University of Queensland Centre for Clinical Research, QLD, Australia.
[19]
Department of Neurology, Auckland City Hospital, Auckland, New Zealand.
[20]
主题词
成年人(Adult);抗体, 单克隆(Antibodies, Monoclonal);抗原, CD20(Antigens, CD20);抗氧化剂(Antioxidants);澳大利亚(Australia);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);巴豆酸盐类(Crotonates);疾病管理(Disease Management);疾病恶化(Disease Progression);药物疗法, 联合(Drug Therapy, Combination);循证医学(Evidence-Based Medicine);延胡索酸盐类(Fumarates);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);羟丁酸盐类(Hydroxybutyrates);免疫球蛋白G(Immunoglobulin G);免疫抑制剂(Immunosuppressive Agents);干扰素β(Interferon-beta);磁共振成像(Magnetic Resonance Imaging);多发性硬化(Multiple Sclerosis);新西兰(New Zealand);腈类(Nitriles);喹诺酮类(Quinolones);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗, 临床研究性(Therapies, Investigational);甲苯胺类(Toluidines);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome)
DOI
10.1016/j.jocn.2014.01.018
PMID
24986155
发布时间
2022-03-30